hOMSC200(Cytora Ltd)

N/A

Report date: 2024/03/14 20:00:41

Base Information

Drug NamehOMSC200(Cytora Ltd)
Drug Alias Name人口腔黏膜干细胞（Cytora Ltd）Human Oral Mucosa Stem Cells(Cytora Ltd)Allogeneic human oral mucosal stem cellshOMSC-200(Cytora Ltd)hOMSC200(Cytora Ltd)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCytora Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCytora Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A